Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
54.5M
-
Number of holders
-
334
-
Total 13F shares, excl. options
-
44.5M
-
Shares change
-
+669K
-
Total reported value, excl. options
-
$4.12B
-
Value change
-
+$64.7M
-
Put/Call ratio
-
1.17
-
Number of buys
-
158
-
Number of sells
-
-182
-
Price
-
$92.91
Significant Holders of Emergent BioSolutions Inc. - Common Stock (EBS) as of Q1 2021
391 filings reported holding EBS - Emergent BioSolutions Inc. - Common Stock as of Q1 2021.
Emergent BioSolutions Inc. - Common Stock (EBS) has 334 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 44.5M shares
of 54.5M outstanding shares and own 81.6% of the company stock.
Largest 10 shareholders include BlackRock Inc. (5.61M shares), VANGUARD GROUP INC (4.93M shares), Neuberger Berman Group LLC (3.2M shares), JANUS HENDERSON GROUP PLC (2.76M shares), STATE STREET CORP (1.91M shares), EARNEST PARTNERS LLC (1.46M shares), MANUFACTURERS LIFE INSURANCE COMPANY, THE (1.2M shares), DIMENSIONAL FUND ADVISORS LP (1.05M shares), Invesco Ltd. (1.05M shares), and GEODE CAPITAL MANAGEMENT, LLC (824K shares).
This table shows the top 334 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.